Avrom S. Caplan

Aug 23, 2024 | jamanetwork.com | Maryn McKenna |Avrom S. Caplan |Gabrielle Todd |Yanchun Zhu

In late 2022, dermatologist Avrom Caplan, MD, started treating a patient who had made multiple emergency department visits for a scaly rash. At Bellevue Hospital, the patient had been diagnosed with ringworm, also known as tinea or dermatophytosis, that had not responded to 3 rounds of topical steroids and antifungals. Caplan, an assistant professor at the NYU Grossman School of Medicine in New York City, saw immediately that the case was unusual.

May 16, 2024 | jamanetwork.com | Avrom S. Caplan |Kaitlin Benedict |Shari R. Lipner |Dallas J. Smith

Introduction Visual inspection cannot reliably distinguish fungal rashes from nonfungal inflammatory skin conditions (eg, dermatitis, eczema).1 Misdiagnosis can lead to unnecessary antifungal use for nonfungal conditions or topical corticosteroid use for fungal rashes, potentially worsening infections.2 When rash causes are uncertain, physicians may prescribe topical antifungal-corticosteroid combination products, which are often less effective and more expensive than monotherapy for fungal...

May 11, 2023 | cdc.gov | Avrom S. Caplan

Weekly / May 12, 2023 / 72(19);536–537 Avrom S. Caplan, MD1; Sudha Chaturvedi, PhD2; YanChun Zhu, MS2; Gabrielle C. Todd, PhD2; Lu Yin, MD1; Adriana Lopez, MD1; Lisa Travis, MD1; Dallas J. Smith, PharmD3,4; Tom Chiller, MD3; Shawn R. Lockhart, PhD3; Karen A. Alroy, DVM5; William G. Greendyke, MD5; Jeremy A. W.